Shorr Score for MRSA Pneumonia

• Risk factors for MRSA (infection with MRSA in the past year, known colonization, necrotizing or cavitary pneumonia, high severity-of-illness scores e.g. PSI/PORT or APACHE II, preceding or concurrent influenza), should also be taken into account when deciding if MRSA treatment is warranted.

• Intended to guide the decision of MRSA treatment initiation. Confirmation studies and clinical judgment should be used to decide if continued MRSA treatment is needed.

Options for MRSA treatment include vancomycin, linezolid, and clindamycin.